OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
VTVT
vTv Therapeutics Inc.
There isn't enough reported data to score VTVT yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
VTVT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
VTVT's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
VTVT PE Valuation
VTVT has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
VTVT Forward outlook
There aren't enough analyst estimates for VTVT to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over VTVT on earnings quality, reporting a profit while its opponent remains loss making.
VTVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.11 | +$3.09 |
| Q1 2026 | $0.02 | +$3.11 |
| Q4 2025 | -$3.62 | -$0.13 |
| Q3 2025 | -$3.40 | +$1.13 |
| Q2 2025 | -$3.20 | +$3.72 |
| Q1 2025 | -$3.09 | +$5.78 |
| Q4 2024 | -$3.49 | +$6.42 |
| Q3 2024 | -$4.53 | +$6.04 |
VTVT lost $0.11 per share over the past year, a smaller loss than the year before.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over VTVT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
VTVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $9K | 0% |
| Q2 2022 | $9K | 0% |
| Q1 2022 | $2M | +103% |
| Q4 2021 | $9K | -100% |
| Q3 2021 | $3M | +42757% |
| Q1 2021 | $987K | +12238% |
| Q4 2020 | $6.4M | +91314% |
VTVT's revenue is growing: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | 63% | N/A |
| Q4 2024 | -28776% | N/A |
| Q1 2024 | -563% | N/A |
| Q4 2022 | -70478% | +52956 points |
| Q2 2022 | -44744% | +7144 points |
| Q1 2022 | -324% | +110 points |
| Q4 2021 | -123433% | -123462 points |
| Q3 2021 | -53% | +40404 points |
VTVT's operating margin was 63% last quarter, up 44808 points from the same quarter a year ago, near the top of its range since 2019.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over VTVT on cash generation, producing positive trailing cash flow while its opponent burns cash.
VTVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.2M | -$5M |
| Q2 2026 | -$11.4M | -$6.3M |
| Q1 2026 | $9.2M | +$14.8M |
| Q4 2025 | -$9.3M | -$4.4M |
| Q3 2025 | -$5.2M | +$1.2M |
| Q2 2025 | -$5.1M | +$1.6M |
| Q1 2025 | -$5.7M | +$1.6M |
| Q4 2024 | -$4.8M | -$1.9M |
VTVT has burned cash in almost every quarter: −$22M over the past year, against −$21M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over VTVT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
VTVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +47% | +4M shares |
| 1 year | +88% | +5.8M shares |
| 3 years | +509% | +10.4M shares |
| 5 years | +747% | +10.9M shares |
| Available history | +1208% | +11.5M shares |
VTVT has 12M diluted shares, up 88% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
VTVT hasn't bought back shares in the past year.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
VTVT Net Leverage
VTVT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
VTVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 3.6 | Oversold |
VTVT's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over VTVT on valuation relative to its sector.
VTVT PE vs Healthcare Sector
| Metric | VTVT | Sector median | Relative |
|---|---|---|---|
| PE | 1,559x | 26x | 5,931% above |
| PE % | 19 | 29 | 10 pts below |
VTVT has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over VTVT on trend strength, trading above more of its moving averages.
VTVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.4 | 22% below |
| 20 week MA | $30.2 | 31% below |
| 50 week MA | $33.0 | 37% below |
| 100 week MA | $25.8 | 20% below |
| 200 week MA | $23.5 | 12% below |
VTVT is in a downtrend: it's below all five of its weekly moving averages, and 12% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over VTVT on returns for 2026, with the stronger performance.
VTVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $71.6 | $82.0 | +15% |
| 2021 | $82.0 | $43.2 | -47% |
| 2022 | $43.2 | $27.2 | -37% |
| 2023 | $27.2 | $11.5 | -58% |
| 2024 | $11.5 | $13.2 | +15% |
| 2025 | $13.2 | $37.9 | +187% |
| 2026 YTD | $37.9 | $20.7 | -45% |
VTVT's yearly returns have swung widely, from +187% in 2025 to −58% in 2023. It's down 45% so far in 2026.